Zongxing Qiu

Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors

Zongxing Qiu, Xianfeng Lin, Mingwei Zhou et al. · Journal of Medicinal Chemistry · 2016 · 72 citations · Full text

Capsid Protein, Antiviral Drug, Hepatitis B Virus +17

Discovery of piperidin-4-yl-aminopyrimidines as HIV-1 reverse transcriptase inhibitors. N-Benzyl derivatives with broad potency against resistant mutant viruses

D Kertesz, Christine Brotherton‐Pleiss, Minmin Yang et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 71 citations · Full text

Antiviral Compound, Medicine, Antiviral Drug Development +11

Discovery of Fluoromethylketone-Based Peptidomimetics as Covalent ATG4B (Autophagin-1) Inhibitors

Zongxing Qiu, Bernd Kuhn, Johannes D. Aebi et al. · ACS Medicinal Chemistry Letters · 2016 · 66 citations · Full text

Cell Autophagy, Medicinal Chemistry, Protein Function +14

Discovery and Pre-Clinical Characterization of Third-Generation 4-H Heteroaryldihydropyrimidine (HAP) Analogues as Hepatitis B Virus (HBV) Capsid Inhibitors

Zongxing Qiu, Xianfeng Lin, Weixing Zhang et al. · Journal of Medicinal Chemistry · 2017 · 58 citations · Full text

Inhibition of Influenza A Virus (H1N1) Fusion by Benzenesulfonamide Derivatives Targeting Viral Hemagglutinin

Lei Zhu, Yuhuan Li, Shaohua Li et al. · PLoS ONE · 2011 · 50 citations · Full text

Viral Replication, Immunology, Molecular Biology +16